Guangzhou Link Health Pharma and George Clinical have signed a term sheet to enter a strategic agreement to launch a clinical development company to deliver trials.
The new independent joint venture company called Link-George Clinical Research will deliver clinical trials for Link Health and associated firms with which it has signed licensing deals.
Link-George plans to commence six clinical trials this year and this is anticipated to develop with the expansion of Link Health’s in-licensed portfolio.
George Clinical CEO James Cheong said: “We are very excited to enter into this joint venture with Link Health as part of a novel platform providing a one-stop service for in-licensing, clinical development, marketing authorisation and commercialisation.
Link-George will merge the expertise of Link Health and George Clinical to accomplish increased efficiency and provide more value across a set of services from pharma licensing to project delivery.
The company offers deep knowledge in the analysis of pharma targets and consultation on pharma licensing and regulatory and commercial landscape in China.
